期刊
ONCOTARGET
卷 7, 期 2, 页码 2054-2069出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.6520
关键词
HBD-3; defensin; necrosis; tumour cell lysis; PI(4,5)P-2
资金
- Australian National Health and Medical Research Council [APP1082383, 1013584]
- Australian Research Council [FT130101349]
- Balmoral Australia Pty Ltd
- Hexima Ltd.
Cationic antimicrobial peptides (CAPs), including taxonomically diverse defensins, are innate defense molecules that display potent antimicrobial and immunomodulatory activities. Specific CAPs have also been shown to possess anticancer activities; however, their mechanisms of action are not well defined. Recently, the plant defensin NaD1 was shown to induce tumour cell lysis by directly binding to the plasma membrane phosphoinositide, phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). The NaD1-lipid interaction was structurally defined by X-ray crystallography, with the defensin forming a dimer that binds PI(4,5)P-2 via its cationic beta 2-beta 3 loops in a 'cationic grip' conformation. In this study, we show that human beta-defensin 3 (HBD-3) contains a homologous beta 2-beta 3 loop that binds phosphoinositides. The binding of HBD-3 to PI(4,5)P-2 was shown to be critical for mediating cytolysis of tumour cells, suggesting a conserved mechanism of action for defensins across diverse species. These data not only identify an evolutionary conservation of CAP structure and function for lipid binding, but also suggest that PIP-binding CAPs could be exploited for novel multifunction therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据